PL2251348T3 - Peptydy oraz ich wykorzystanie - Google Patents

Peptydy oraz ich wykorzystanie

Info

Publication number
PL2251348T3
PL2251348T3 PL10009304T PL10009304T PL2251348T3 PL 2251348 T3 PL2251348 T3 PL 2251348T3 PL 10009304 T PL10009304 T PL 10009304T PL 10009304 T PL10009304 T PL 10009304T PL 2251348 T3 PL2251348 T3 PL 2251348T3
Authority
PL
Poland
Prior art keywords
peptides
Prior art date
Application number
PL10009304T
Other languages
English (en)
Inventor
Deborah O'neil
Original Assignee
Novabiotics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novabiotics Ltd filed Critical Novabiotics Ltd
Publication of PL2251348T3 publication Critical patent/PL2251348T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PL10009304T 2007-02-02 2008-01-28 Peptydy oraz ich wykorzystanie PL2251348T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US89928307P 2007-02-02 2007-02-02
GBGB0702020.9A GB0702020D0 (en) 2007-02-02 2007-02-02 Peptides and their use
EP08701955A EP2114988A2 (en) 2007-02-02 2008-01-28 Peptides and their use
EP10009304.6A EP2251348B1 (en) 2007-02-02 2008-01-28 Peptides and their use

Publications (1)

Publication Number Publication Date
PL2251348T3 true PL2251348T3 (pl) 2014-05-30

Family

ID=37891189

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10009304T PL2251348T3 (pl) 2007-02-02 2008-01-28 Peptydy oraz ich wykorzystanie

Country Status (16)

Country Link
US (1) US9169290B2 (pl)
EP (2) EP2251348B1 (pl)
JP (2) JP2010517988A (pl)
CN (1) CN101679487B (pl)
AU (1) AU2008211789B2 (pl)
CA (1) CA2706744C (pl)
CY (1) CY1115140T1 (pl)
DK (1) DK2251348T3 (pl)
ES (1) ES2449615T3 (pl)
GB (1) GB0702020D0 (pl)
HR (1) HRP20140185T1 (pl)
NZ (1) NZ578970A (pl)
PL (1) PL2251348T3 (pl)
PT (1) PT2251348E (pl)
SI (1) SI2251348T1 (pl)
WO (1) WO2008093060A2 (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0702021D0 (en) 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
WO2009153418A1 (fr) * 2008-06-16 2009-12-23 Centre National De La Recherche Scientifique (C.N.R.S) Peptides harp inhibant la croissance tumorale
FR2941231B1 (fr) 2009-01-16 2016-04-01 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
CA2865791C (en) 2011-03-03 2019-10-08 Cidara Therapeutics, Inc. Antifungal agents and uses thereof
CN102432672A (zh) * 2011-12-13 2012-05-02 重庆理工大学 一组新型合成抗菌肽及其应用
GB201204457D0 (en) * 2012-03-14 2012-04-25 Novabiotics Ltd Polypeptides and their use
SI3677252T1 (sl) 2012-03-19 2024-02-29 Cidara Therapeutics, Inc. Sheme odmerjanja za spojine iz razreda ehinokandinov
US20160250285A1 (en) 2013-10-30 2016-09-01 University Of Western Australia Neuroprotective peptides
GB201405891D0 (en) * 2014-04-02 2014-05-14 Novabiotics Ltd Modified antimicrobial peptides
RS59119B1 (sr) 2014-05-21 2019-09-30 Entrada Therapeutics Inc Peptidi koji prodiru u ćelije i postupci za njihovo pravljenje i upotrebu
US10815276B2 (en) 2014-05-21 2020-10-27 Entrada Therapeutics, Inc. Cell penetrating peptides and methods of making and using thereof
WO2016033368A1 (en) 2014-08-27 2016-03-03 Ohio State Innovation Foundation Improved peptidyl calcineurin inhibitors
US9675659B2 (en) 2015-08-21 2017-06-13 Trilogy Therapeutics, Inc. Methods of treating lung infection with caspofungin
US10369188B2 (en) 2016-01-08 2019-08-06 Cidara Therapeutics, Inc. Methods for preventing and treating pneumocystis infections
JP7224916B2 (ja) 2016-03-16 2023-02-20 シダラ セラピューティクス インコーポレーテッド 真菌感染の処置のための投薬レジメン
GB201609925D0 (en) * 2016-06-07 2016-07-20 Novabiotics Ltd Formulation
WO2018191692A1 (en) * 2017-04-14 2018-10-18 Cidara Therapeutics, Inc. Methods for treating fungal infections
MA49576A (fr) 2017-07-12 2021-04-07 Cidara Therapeutics Inc Compositions et méthodes pour le traitement d'infections fongiques
CA3078504A1 (en) 2017-10-04 2019-04-11 Ohio State Innovation Foundation Bicyclic peptidyl inhibitors
WO2019148194A2 (en) 2018-01-29 2019-08-01 Ohio State Innovation Foundation Peptidyl inhibitors of calcineurin-nfat interaction
US11793884B2 (en) 2018-01-29 2023-10-24 Ohio State Innovation Foundation Cyclic peptidyl inhibitors of CAL-PDZ binding domain
TW201945014A (zh) 2018-02-22 2019-12-01 美商安卓達治療股份有限公司 用於治療粒線體性神經胃腸腦病變之組合物及方法
US11344614B2 (en) * 2018-09-29 2022-05-31 Emergex Vaccines Holding Ltd. Pharmaceutical compositions comprising dengue virus-specific multiple HLA-binding T cell epitopes
KR102429281B1 (ko) * 2020-05-25 2022-08-05 (주)노바셀테크놀로지 신규 안구건조증 치료용 약학적 조성물
GB202010268D0 (en) * 2020-07-03 2020-08-19 Novabiotics Ltd Nail formulations and treatment regimes
CN113336824A (zh) * 2021-04-30 2021-09-03 重庆理工大学 一种多肽在作为pd-1/pd-l1蛋白-蛋白相互作用(ppi)调节剂中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0149254A3 (en) 1983-12-29 1987-01-28 The Research Foundation Of State University Of New York Fungicidal polypeptide compositions containing l-histidine
US5646120A (en) * 1990-10-24 1997-07-08 Allelix Biopharmaceuticals, Inc. Peptide-based inhibitors of HIV replication
IL132941A0 (en) * 1997-05-21 2001-03-19 Univ Leland Stanford Junior Composition and method for enhancing transport across biological membranes
US8038984B2 (en) * 1998-06-20 2011-10-18 Washington University Membrane-permeant peptide complexes for treatment of sepsis
US7049395B2 (en) * 2000-05-02 2006-05-23 Yale University Anti-inflammatory compounds and uses thereof
US20040142892A1 (en) * 2001-04-30 2004-07-22 The University Of British Columbia Autogene nucleic acids encoding a secretable RNA polymerase
US7033991B2 (en) * 2001-07-16 2006-04-25 Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College Inhibiting furin with polybasic peptides
JP2005525998A (ja) * 2001-08-30 2005-09-02 プラエシス ファーマシューティカルズ インコーポレーテッド 炎症性疾患の治療のための方法および組成物
WO2004050685A2 (en) 2002-11-29 2004-06-17 Adaptive Therapeutics, Inc. Antifungal therapeutic agents
US7125842B2 (en) * 2003-04-07 2006-10-24 Canbas Co. Ltd. Anti-fungal compounds and methods of use
US20050203892A1 (en) * 2004-03-02 2005-09-15 Jonathan Wesley Dynamically integrating disparate systems and providing secure data sharing
EP1778720B1 (en) * 2004-08-18 2010-09-01 Novabiotics Limited Antimicrobial peptides comprising an arginine- and/or lysine-containing motif
EP2357190A3 (en) * 2005-12-22 2011-08-24 Novabiotics Limited Cyclic antimicrobial peptides
JP4520477B2 (ja) * 2006-10-31 2010-08-04 株式会社マルハニチロ食品 抗真菌ペプチドまたはそれを含有するペプチド組成物とその製造方法
GB0702021D0 (en) 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
GB0702022D0 (en) 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use

Also Published As

Publication number Publication date
HK1145506A1 (en) 2011-04-21
EP2114988A2 (en) 2009-11-11
ES2449615T3 (es) 2014-03-20
EP2251348A2 (en) 2010-11-17
EP2251348A3 (en) 2011-03-02
NZ578970A (en) 2012-04-27
AU2008211789A1 (en) 2008-08-07
AU2008211789B2 (en) 2013-11-14
HRP20140185T1 (hr) 2014-05-09
PT2251348E (pt) 2014-03-06
SI2251348T1 (sl) 2014-05-30
JP2014012667A (ja) 2014-01-23
GB0702020D0 (en) 2007-03-14
CN101679487B (zh) 2018-04-03
CA2706744A1 (en) 2008-08-07
CN101679487A (zh) 2010-03-24
EP2251348B1 (en) 2014-01-15
JP2010517988A (ja) 2010-05-27
WO2008093060A2 (en) 2008-08-07
DK2251348T3 (en) 2014-03-03
CY1115140T1 (el) 2016-12-14
JP5882260B2 (ja) 2016-03-09
CA2706744C (en) 2017-12-05
US20100184696A1 (en) 2010-07-22
US9169290B2 (en) 2015-10-27
WO2008093060A3 (en) 2008-10-23

Similar Documents

Publication Publication Date Title
GB0702020D0 (en) Peptides and their use
GB0712670D0 (en) Isolated peptides and uses thereof
IL205571A0 (en) 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin
TWI561237B (en) Substituted dihydropyrazolones and their use
EP2185692A4 (en) HCO32 AND HCO27 AND RELATED EXAMPLES
GB0701426D0 (en) Compounds and their use
GB0702021D0 (en) Peptides and their use
GB0708376D0 (en) Novel polypeptides and uses thereof
GB0702022D0 (en) Peptides and their use
EP1976864A4 (en) NEW PEPTIDE AND ITS USE
IL195525A0 (en) Replikin peptides and uses thereof
PL2464656T3 (pl) Nowy peptyd i jego zastosowanie
GB2460178B (en) Depsipeptides and their therapeutic use
GB2460181B (en) Depsipeptides and their therapeutic use
PL2222692T3 (pl) Syntetyczny peptyd wiążący się z ludzkim CD154 i jego zastosowania
GB0604187D0 (en) Peptide and uses thereof
GB2460180B (en) Depsipeptides and their therapeutic use
IL192800A0 (en) Fgf2-binding peptides and uses thereof
GB0617564D0 (en) Peptides and methods
EP2168951A4 (en) AZOLYLMETHYLIDENHYDRAZINE DERIVATIVE AND ITS USE
GB0710813D0 (en) Peptides and uses thereof
GB0800502D0 (en) Peptides and their uses
GB0816561D0 (en) Peptides and uses thereof
HU0800405D0 (en) Ewnvironment-friendly biocidis and use thereof
GB0800699D0 (en) F7 polypeptides and use thereof